Pathogenesis of Chronic Liver Injury and Hepatocellular Carcinoma in Alpha-1-Antitrypsin Deficiency

: Alpha-1-antitrypsin (AT) deficiency is the most common genetic cause of liver disease in children. In addition to chronic liver inflammation and injury, it has a predilection to cause hepatocellular carcinoma later in life. The deficiency is caused by a mutant protein, ATZ, which is retained in the endoplasmic reticulum (ER) in a polymerized form rather than secreted into the blood in its monomeric form. The histologic hallmark of the disease is ATZ-containing globules in some, but not all, hepatocytes. Liver injury results from a gain-of-toxic function mechanism in which mutant ATZ retained in the ER initiates a series of pathologic events, but little is known about the mechanism by which this leads to carcinogenesis. Several recent observations from my laboratory have led to a novel hypothetical paradigm for carcinogenesis in AT deficiency in which globule-containing hepatocytes are “sick,” relatively growth suppressed, but also elaborating trans-acting regenerative signals. These signals are received and transduced by globule-devoid hepatocytes, which, because they are younger and have a lesser load of accumulated ATZ, have a selective proliferative advantage. Chronic regeneration in the presence of tissue injury leads to adenomas and ultimately carcinomas. Aspects of this hypothetical paradigm may also explain the proclivity for hepatocarcinogenesis in other chronic liver diseases, including other genetic diseases, viral hepatitis, and nonalcoholic steatohepatitis.

[1]  E. Silverman,et al.  A family study of the variability of pulmonary function in α1-antitrypsin deficiency: Quantitative phenotypes , 1990 .

[2]  Rinat Abramovitch,et al.  NF-kappaB functions as a tumour promoter in inflammation-associated cancer. , 2004, Nature.

[3]  Myeong-Hee Yu,et al.  A Thermostable Mutation Located at the Hydrophobic Core of α1-Antitrypsin Suppresses the Folding Defect of the Z-type Variant (*) , 1995, The Journal of Biological Chemistry.

[4]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[5]  J. Brodsky,et al.  Proteasome-dependent endoplasmic reticulum-associated protein degradation: An unconventional route to a familiar fate , 1996 .

[6]  J. Teckman,et al.  Mitochondrial autophagy and injury in the liver in α1-antitrypsin deficiency , 2004 .

[7]  D. Lomas,et al.  The mechanism of Z α1-antitrypsin accumulation in the liver , 1993, Nature.

[8]  Chien-Fu Chen,et al.  Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. , 2003, The American journal of pathology.

[9]  D. Ron,et al.  Translational control in the endoplasmic reticulum stress response. , 2002, The Journal of clinical investigation.

[10]  H. Pahl,et al.  Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention , 1996, The Journal of cell biology.

[11]  Takahiro Kamimoto,et al.  Intracellular Inclusions Containing Mutant α1-Antitrypsin Z Are Propagated in the Absence of Autophagic Activity* , 2006, Journal of Biological Chemistry.

[12]  Guido Kroemer,et al.  Hsp27 negatively regulates cell death by interacting with cytochrome c , 2000, Nature Cell Biology.

[13]  J. Teckman,et al.  Role of ubiquitin in proteasomal degradation of mutant alpha(1)-antitrypsin Z in the endoplasmic reticulum. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[14]  D. Lomas,et al.  Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. , 2002, The Journal of clinical investigation.

[15]  L. Muglia,et al.  Analyses of hepatocellular proliferation in a mouse model of α‐1‐antitrypsin deficiency , 2004 .

[16]  D. Perlmutter,et al.  Accumulation of Mutant α1-Antitrypsin Z in the Endoplasmic Reticulum Activates Caspases-4 and -12, NFκB, and BAP31 but Not the Unfolded Protein Response* , 2005, Journal of Biological Chemistry.

[17]  J. Teckman,et al.  A Naturally Occurring Nonpolymerogenic Mutant of α1-Antitrypsin Characterized by Prolonged Retention in the Endoplasmic Reticulum* , 2001, The Journal of Biological Chemistry.

[18]  H. Hauri,et al.  A high-molecular-weight complex of membrane proteins BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Kohlwein,et al.  Association between the endoplasmic reticulum and mitochondria of yeast facilitates interorganelle transport of phospholipids through membrane contact. , 1999, European journal of biochemistry.

[20]  Yan Liu,et al.  Processing by Endoplasmic Reticulum Mannosidases Partitions a Secretion-impaired Glycoprotein into Distinct Disposal Pathways* , 2000, The Journal of Biological Chemistry.

[21]  M. Grompe,et al.  Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I , 1996, Nature Genetics.

[22]  D. Perlmutter,et al.  Cell-specific involvement of HNF-1β in α1-antitrypsin gene expression in human respiratory epithelial cells , 2002 .

[23]  J. Dubuisson.  Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. , 2000, Current topics in microbiology and immunology.

[24]  J. Teckman,et al.  Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[25]  R. Tanguay,et al.  Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia. , 2003, Human pathology.

[26]  T Sveger,et al.  Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. , 1976, The New England journal of medicine.

[27]  S. Geller,et al.  Histopathology of α1‐antitrypsin liver disease in a transgenic mouse model , 1990 .

[28]  Cliff,et al.  Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. , 1989, The Journal of clinical investigation.

[29]  J. Carlson,et al.  Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. , 1986, The New England journal of medicine.

[30]  S. Jentsch,et al.  Role of the proteasome in membrane extraction of a short‐lived ER‐transmembrane protein , 1998, The EMBO journal.

[31]  Michael Karin,et al.  IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.

[32]  J. Teckman,et al.  The Proteasome Participates in Degradation of Mutant α1-Antitrypsin Z in the Endoplasmic Reticulum of Hepatoma-derived Hepatocytes* , 2001, The Journal of Biological Chemistry.

[33]  A Janoff,et al.  Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. , 1985, The American review of respiratory disease.

[34]  R. Crystal,et al.  Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. , 1990, The Journal of clinical investigation.

[35]  Yan Liu,et al.  Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs. , 2002, Molecular biology of the cell.

[36]  T. Sveger.  The Natural History of Liver Disease in (α1‐Antitrypsin Deficient Children , 1988 .

[37]  D. Lomas,et al.  Mutations Which Impede Loop/Sheet Polymerization Enhance the Secretion of Human α1-Antitrypsin Deficiency Variants (*) , 1995, The Journal of Biological Chemistry.

[38]  M. Matsui,et al.  In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. , 2003, Molecular biology of the cell.

[39]  H. Rootwelt,et al.  Self-induced correction of the genetic defect in tyrosinemia type I. , 1994, The Journal of clinical investigation.

[40]  M. Iordanov,et al.  Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death , 2004, Hepatology.

[41]  S. Ōmura,et al.  Degradation of a Mutant Secretory Protein, α1-Antitrypsin Z, in the Endoplasmic Reticulum Requires Proteasome Activity* , 1996, The Journal of Biological Chemistry.

[42]  T. Roskams,et al.  Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. , 2003, The American journal of pathology.

[43]  R. Carrell,et al.  SMOKING, LUNG FUNCTION, AND α1-ANTITRYPSIN DEFICIENCY , 1985, The Lancet.

[44]  J. Brodsky,et al.  Characterization of an ERAD gene as VPS30/ATG6 reveals two alternative and functionally distinct protein quality control pathways: one for soluble Z variant of human alpha-1 proteinase inhibitor (A1PiZ) and another for aggregates of A1PiZ. , 2005, Molecular biology of the cell.

[45]  S J Young,et al.  Electron tomography of neuronal mitochondria: three-dimensional structure and organization of cristae and membrane contacts. , 1997, Journal of structural biology.

[46]  R. Kaufman,et al.  Signaling the Unfolded Protein Response from the Endoplasmic Reticulum* , 2004, Journal of Biological Chemistry.

[47]  V. P. Chacko,et al.  Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? , 2001, Cancer research.

[48]  Arnold J. Levine,et al.  Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  F. Chisari,et al.  Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences , 1987, Journal of virology.

[50]  R. Carrell,et al.  Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. , 1989, Biochemistry.

[51]  G. Shore,et al.  Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol , 2003, The Journal of cell biology.

[52]  D. Lomas,et al.  The mechanism of Z alpha 1-antitrypsin accumulation in the liver. , 1992, Nature.

[53]  J. Pierce,et al.  Synthesis of stress proteins is increased in individuals with homozygous PiZZ alpha 1-antitrypsin deficiency and liver disease. , 1989, The Journal of clinical investigation.

[54]  D. Perlmutter,et al.  Grp78, Grp94, and Grp170 interact with alpha1-antitrypsin mutants that are retained in the endoplasmic reticulum. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[55]  S. Geller,et al.  Hepatocarcinogenesis is the sequel to hepatitis in Z#2 α1‐antitrypsin transgenic mice: Histopathological and DNA ploidy studies , 1994, Hepatology.

[56]  Govind Bhagat,et al.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. , 2003, The Journal of clinical investigation.

[57]  K. E. Moore,et al.  A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Geller,et al.  Neonatal hepatitis induced by alpha 1-antitrypsin: a transgenic mouse model. , 1988, Science.

[59]  D. Perlmutter.  Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. , 2002, The Journal of clinical investigation.